Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Spruce Biosciences secures a combined $5.5 million strategic investment from Cure Sanfilippo Foundation and National MPS Society to enhance patient access for TA-ERT EAP.

Aug 13, 2026•about 2 hours ago
San FranciscoBiotechnology

Description

Spruce Biosciences, a late-stage biopharmaceutical company, announced a strategic investment of $5.5 million from Cure Sanfilippo Foundation and the National MPS Society. This funding will be used to partially support the TA-ERT EAP initiative. The investment aims to improve patient access to critical therapies for neurological disorders. This partnership highlights the commitment to addressing significant medical needs in this area.

Company Information

Company

Spruce Biosciences

Location

611 Gateway Boulevard, Suite 740

San Francisco, California, United States

About

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company aims to address significant unmet medical needs through innovative treatment solutions. Spruce has a particular focus on rare diseases and is committed to serving patient communities. They are known for their work in enzyme replacement therapies.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Spruce Biosciences's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.